Moroianu, L.-A.; Cecilia, C.; Ardeleanu, V.; Pantea Stoian, A.; Cristescu, V.; Barbu, R.-E.; Moroianu, M.
Clinical Study of Serum Serotonin as a Screening Marker for Anxiety and Depression in Patients with Type 2 Diabetes. Medicina 2022, 58, 652.
https://doi.org/10.3390/medicina58050652
AMA Style
Moroianu L-A, Cecilia C, Ardeleanu V, Pantea Stoian A, Cristescu V, Barbu R-E, Moroianu M.
Clinical Study of Serum Serotonin as a Screening Marker for Anxiety and Depression in Patients with Type 2 Diabetes. Medicina. 2022; 58(5):652.
https://doi.org/10.3390/medicina58050652
Chicago/Turabian Style
Moroianu, Lavinia-Alexandra, Curis Cecilia, Valeriu Ardeleanu, Anca Pantea Stoian, Vasilica Cristescu, Raisa-Eloise Barbu, and Marius Moroianu.
2022. "Clinical Study of Serum Serotonin as a Screening Marker for Anxiety and Depression in Patients with Type 2 Diabetes" Medicina 58, no. 5: 652.
https://doi.org/10.3390/medicina58050652
APA Style
Moroianu, L.-A., Cecilia, C., Ardeleanu, V., Pantea Stoian, A., Cristescu, V., Barbu, R.-E., & Moroianu, M.
(2022). Clinical Study of Serum Serotonin as a Screening Marker for Anxiety and Depression in Patients with Type 2 Diabetes. Medicina, 58(5), 652.
https://doi.org/10.3390/medicina58050652